Biora Therapeutics, Inc. (BIOR)

Biora Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	15.21	30.49	88.4	92.08	33.04	49.01
Short-Term Investments	0	0	0	0	0	20.2
Cash & Cash Equivalents	15.21	30.49	88.4	92.08	33.04	69.21
Cash Growth	-50.10%	-65.51%	-4.00%	178.66%	-52.25%	-
Receivables	0	0	0.65	6.63	22.19	1.95
Inventory	0	0	0	0	10.94	7.62
Other Current Assets	3.86	7.63	9.73	27.63	8.48	10.17
Total Current Assets	19.07	38.12	98.78	126.34	74.65	88.95
Property, Plant & Equipment	2.77	3.14	3.67	8.11	15.89	15.34
Goodwill and Intangibles	6.07	6.07	6.07	6.07	10.99	11.92
Other Long-Term Assets	3.3	6.2	0.33	13.92	0.2	0.19
Total Long-Term Assets	12.14	15.41	10.06	28.1	27.08	27.45
Total Assets	31.22	53.53	108.84	154.44	101.73	116.4
Accounts Payable	2.84	3.61	8.71	17.38	15.75	11.04
Current Debt	1.98	0	0.01	0.34	0.97	1.23
Other Current Liabilities	58.15	19.7	52.89	54.95	83.62	65.79
Total Current Liabilities	62.97	23.31	61.61	72.67	100.34	78.06
Long-Term Debt	43.74	127.81	126.39	160.2	72.41	71.51
Other Long-Term Liabilities	25.93	4.7	5.81	28.56	12.86	3.8
Total Long-Term Liabilities	69.66	132.51	132.21	188.76	85.26	75.31
Total Liabilities	132.64	155.81	193.82	261.43	185.6	153.37
Total Debt	45.71	127.81	126.4	160.54	73.37	72.74
Debt Growth	-64.23%	1.11%	-21.26%	118.80%	0.87%	-
Retained Earnings	-950.96	-826.84	-788.69	-541.27	-348.48	-142.47
Shareholders' Equity	-101.42	-102.29	-84.98	-106.99	-83.87	-36.97
Net Cash / Debt	-30.5	-97.33	-38.01	-68.47	-40.33	-3.53
Net Cash Per Share	-1.93	-12.75	-9.88	-62.21	-206.50	-18.96
Working Capital	-43.9	14.81	37.17	53.67	-25.69	10.89
Book Value Per Share	-6.43	-13.40	-22.09	-97.22	-429.45	-198.44

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).